Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1996Antimicrobial Agents and ChemotherapyOpen Access

Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli

View Full Paper
Ask AI
Bookmark
Share

Authors

JVJordi VilàHospital Clínic de BarcelonaJRJoaquı́m RuizUniversidad Científica del SurPGPilar GoñiUniversidad de Zaragoza

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vilà et al. (1996) studied this question.

synapsesocial.com/papers/6a1bd3fdb33628da419ceb6fhttps://doi.org/10.1128/aac.40.2.491
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli1986 · 257 citations
  2. 2Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-121986 · 193 citations
  3. 3DNA gyrase: an enzyme that introduces superhelical turns into DNA.1976 · 1,214 citations
  4. 4Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition1994 · 162 citations
  5. 5Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication in vitro.1993 · 146 citations